MFDS — authorised 4 February 2022
- Marketing authorisation holder: BIOVERATIV THERAPEUTICS INC
- Status: likely_approved
🇰🇷 Enjaymo in South Korea
MFDS authorised Enjaymo on 4 February 2022
Marketing authorisation
Enjaymo in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Immunology approved in South Korea
Frequently asked questions
Is Enjaymo approved in South Korea?
Yes. MFDS authorised it on 4 February 2022.
Who is the marketing authorisation holder for Enjaymo in South Korea?
BIOVERATIV THERAPEUTICS INC holds the South Korean marketing authorisation.